BVS - Bioventus Inc
Bioventus Inc Logo

BVS - Bioventus Inc

https://www.bioventus.com
Buy Momentum: Bearish
Recent News
Powered by Alpha Vantage
AI Tools
Key Metrics
Trend: Range-Bound
As of 2025-09-10 (Snapshot)

Bioventus Inc., a medical device company, focuses on developing and commercializing clinical treatments that involve and enhance the body's natural healing process in the United States and internationally. The company is headquartered in Durham, North Carolina.

52W High
$14.38
52W Low
$5.81
MA Status:
50D: Above 200D: Below
Beta (~1 neutral, <0.9 lower risk)
0.84
Valuation
Attractive
As of 2025-06-30 (Overview)
Trailing P/E (<15 better)
239.67
Forward P/E (<15 better)
8.17
EV/EBITDA (<8 favorable)
9.08
EV/Revenue (<3 favorable)
1.40
P/S (TTM) (<3 favorable)
0.85
P/B (<3 favorable)
2.98
Ownership
Balanced
Source: Overview
Insiders (1–5% typical)
11.77%
Institutions (25–75% balanced)
73.58%
Shares Outstanding
66,892,000
Float
33,720,400
Dividend Yield (2–6% sweet spot)
N/A
Ex‑Dividend Date
N/A
Income & Growth
Profitability: Weak
As of 2025-06-30 (Overview)
Revenue (TTM)
564,142,000
Gross Profit (TTM)
381,353,000
EPS (TTM)
0.03
Profit Margin (>10% good)
0.00%
Operating Margin (TTM) (higher better)
0.12%
ROE (TTM) (>15% strong)
0.01%
EPS YoY (Quarterly) (>10% good)
N/A
Revenue YoY (Quarterly) (>8% good)
-0.02
Momentum
Bearish momentum
Value
0.0614
Previous
0.0632
Trend
Falling
Signal Cross
No cross
As of
Sep. 12, 2025